Teladoc Health faces challenges with declining revenues & intense competition, but UpLift's potential and future efficiency keep it a hold.

The Procter & Gamble Company's stagnating revenue growth and premium valuation suggest it's time to explore better value opportunities. Click for my PG update.

FB Bancorp, Inc. trades at a discount but struggles with profitability and asset quality. Click for why FBLA's low valuation isn't enough for a buy recommendation.

Discover why American Express remains a long-term buy with strong financials and brand appeal, but learn why current valuations may require caution.

John Hancock Disciplined Value Mid Cap Fund outperformed the benchmark. The Russell MidCap Value Index—the fund’s benchmark—returned –2.11% in the first quarter.

Discover why Jacobs' transformation into a tech-driven firm faces challenges. Explore insights on valuation, efficiency, and investment risks. Click here to read.

Explore Kimberly-Clark Corporation's 2024 performance, impacted by currency headwinds but boosted by margin gains. Click for my first look at KMB stock.

Kuaishou Technology (OTCPK:KUASF) Q1 2025 Results Conference Call May 27, 2025 7:00 AM ETCompany ParticipantsMatthew Zhao - Vice President, Capital Markets...

MNTN targets TV ad revolution for smaller brands with data-driven solutions. Strong growth excites, but high risks warrant caution. Read the latest IPO analysis on this stock here.

New Gold Inc. offers strong upside potential with increased production, higher gold prices, and expanded mine life.

Groupon downgraded to Strong Sell with a $10 price target due to fragile valuation, churn risks, and lack of broad-based growth.

Discover why Cellebrite (CLBT) holds a 'Hold' rating amid valuation concerns. Explore product momentum, growth hurdles, and FedRAMP delay impacts. Click to read.

We initiate MS with a Buy rating and $162 PT, as market underestimates durability and scale of earnings rebound underway. Click here to read why MS is a Buy.

Discover why SYF faces a 'hold' rating amid financial uncertainties, limited upside, modest dividend growth, and technical range-bound trading.

Discover why Jollibee's international expansion and management decisions may be undermining its strong brand and performance. Click here to read more.

Fabrinet delivers solid revenue growth, driven by datacom and diversified end markets, though earnings growth has lagged sales recently. Read why FN is a Hold.

Buffer strategies have experienced notable investor interest amid the 2025 bout of equity market volatility. Click to read.

The TCW Securitized Bond Fund I-Class (“Fund”) gained 3.65% net of fees in the first quarter of 2025 to finish ahead of the Bloomberg U.S. Aggregate Index by 87 bps.

Discover GLDD's 300%+ net income growth in 2024, driven by $1B+ backlog and federal infrastructure tailwinds.

The TCW Emerging Markets Income Fund, I Class returned 2.31% for the first quarter of 2025, outperforming the JP Morgan EMBI Global Diversified return of 2.24% by 7 bps.